Clinical and immune responses to neoadjuvant fulvestrant with or without enzalutamide in ER+/Her2- breast cancer
ER+/Her2-乳腺癌患者接受新辅助氟维司群联合或不联合恩扎卢胺治疗的临床和免疫反应
期刊:NPJ Breast Cancer
影响因子:7.6
doi:10.1038/s41523-024-00697-5
Elias, Anthony D; Staley, Alyse W; Fornier, Monica; Vidal, Gregory A; Alami, Vida; Sams, Sharon; Spoelstra, Nicole S; Goodspeed, Andrew; Kabos, Peter; Diamond, Jennifer R; Shagisultanova, Elena; Gallagher, Rosa I; Wulfkuhle, Julia D; Petricoin, Emanuel F; Zolman, Kathryn L; McSpadden, Tessa; Jordan, Kimberly R; Slansky, Jill E; Borges, Virginia F; Gao, Dexiang; Richer, Jennifer K